| Susan C Sanders, MD | |
|
335 Penny Ln, Concord, NC 28025-1221 | |
| (704) 784-5901 | |
| (704) 721-0413 |
| Full Name | Susan C Sanders |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 36 Years |
| Location | 335 Penny Ln, Concord, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730165069 | NPI | - | NPPES |
| 8921464 | Medicaid | NC | |
| 110081554 | Other | NC | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 34216 (North Carolina) | Primary |
| 207NS0135X | Dermatology - Procedural Dermatology | 34216 (North Carolina) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Group Of The Carolinas | 3678514759 | 20 |
News Archive
The nonprofits Ludwig Cancer Research (Ludwig) and the Cancer Research Institute (CRI) announced today an agreement with VentiRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company, to conduct a clinical trial with motolimod (VTX-2337) combined with other immunotherapy agents available to Ludwig and CRI through other industry partnerships.
CSMA has recently developed a unique range of tests for the characterisation and analysis of catheter tubing. CSMA is the only company in Europe to offer a standard suite of tests related specifically to catheter tubing manufacturers.
High physical work demands are linked to an increased risk of death from ischemic heart disease (IHD)—but only for men who aren't physically fit, reports a study in the November Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions of North Carolinians whose drinking water comes from private wells, and current safety regulations don't address the problem, a new Duke University study finds.
In direct response to recommendations made by a National Institutes of Health scientific consensus panel, the ECOG-ACRIN Cancer Research Group announced today the opening of E4112, a clinical trial for women with newly diagnosed ductal carcinoma in situ (DCIS) of the breast who, together with their doctors, will use the results of a magnetic resonance imaging (MRI) exam to determine whether to undergo a lumpectomy or a mastectomy.
› Verified 3 days ago
| Entity Name | Dermatology Group Of The Carolinas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437110772 PECOS PAC ID: 3678514759 Enrollment ID: O20050518001227 |
News Archive
The nonprofits Ludwig Cancer Research (Ludwig) and the Cancer Research Institute (CRI) announced today an agreement with VentiRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company, to conduct a clinical trial with motolimod (VTX-2337) combined with other immunotherapy agents available to Ludwig and CRI through other industry partnerships.
CSMA has recently developed a unique range of tests for the characterisation and analysis of catheter tubing. CSMA is the only company in Europe to offer a standard suite of tests related specifically to catheter tubing manufacturers.
High physical work demands are linked to an increased risk of death from ischemic heart disease (IHD)—but only for men who aren't physically fit, reports a study in the November Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions of North Carolinians whose drinking water comes from private wells, and current safety regulations don't address the problem, a new Duke University study finds.
In direct response to recommendations made by a National Institutes of Health scientific consensus panel, the ECOG-ACRIN Cancer Research Group announced today the opening of E4112, a clinical trial for women with newly diagnosed ductal carcinoma in situ (DCIS) of the breast who, together with their doctors, will use the results of a magnetic resonance imaging (MRI) exam to determine whether to undergo a lumpectomy or a mastectomy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan C Sanders, MD 335 Penny Ln, Concord, NC 28025-1221 Ph: (704) 784-5901 | Susan C Sanders, MD 335 Penny Ln, Concord, NC 28025-1221 Ph: (704) 784-5901 |
News Archive
The nonprofits Ludwig Cancer Research (Ludwig) and the Cancer Research Institute (CRI) announced today an agreement with VentiRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company, to conduct a clinical trial with motolimod (VTX-2337) combined with other immunotherapy agents available to Ludwig and CRI through other industry partnerships.
CSMA has recently developed a unique range of tests for the characterisation and analysis of catheter tubing. CSMA is the only company in Europe to offer a standard suite of tests related specifically to catheter tubing manufacturers.
High physical work demands are linked to an increased risk of death from ischemic heart disease (IHD)—but only for men who aren't physically fit, reports a study in the November Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions of North Carolinians whose drinking water comes from private wells, and current safety regulations don't address the problem, a new Duke University study finds.
In direct response to recommendations made by a National Institutes of Health scientific consensus panel, the ECOG-ACRIN Cancer Research Group announced today the opening of E4112, a clinical trial for women with newly diagnosed ductal carcinoma in situ (DCIS) of the breast who, together with their doctors, will use the results of a magnetic resonance imaging (MRI) exam to determine whether to undergo a lumpectomy or a mastectomy.
› Verified 3 days ago
Brian Scott Walther, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413 | |
Mr. Aaron Sidscott Wever, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413 | |
Ada Tolutope Ogunsiakan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Park Dr, Ste 460, Concord, NC 28025 Phone: 704-403-2777 | |
Maryanna C Ter Poorten, MD Dermatology Medicare: Medicare Enrolled Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413 | |
Joseph J Roche, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413 | |
Dr. Nathaniel Allen Slater, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 | |
Dr. Dhwani S Mehta, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413 |